NetworkNewsBreaks – Pressure BioSciences, Inc. (
Post# of 1354
(Total Views: 246)
Posted On: 03/12/2020 2:28:06 PM
NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Order for Game-Changing UST System from Can B Corp. (CANBD)
Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) (“UST”)-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. The nanoemulsions are expected to exhibit bioavailability levels that far exceed the absorption efficiency of today’s macro or microemulsions of CBD oil. “Importantly, the optimized effectiveness for the consumer also translates into allowing top-shelf manufacturers like Can B Corp to achieve targeted product effects from much lower levels of cannabinoids in their marketed products,” Pressure BioSciences President and CEO Richard T. Schumacher said in the news release. “This should offer them a dramatic new cost efficiency, for both ingested or topically applied products. We also believe that Can B Corp’s routine use of our BaroShear K45 system will allow them to increase even more the current high-quality level of their products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer, Can B Corp. (OTCQB: CANBD). According to the update, the order is for one of PBIO’s proprietary BaroShear K45 Ultra Shear Technology(TM) (“UST”)-based systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. The nanoemulsions are expected to exhibit bioavailability levels that far exceed the absorption efficiency of today’s macro or microemulsions of CBD oil. “Importantly, the optimized effectiveness for the consumer also translates into allowing top-shelf manufacturers like Can B Corp to achieve targeted product effects from much lower levels of cannabinoids in their marketed products,” Pressure BioSciences President and CEO Richard T. Schumacher said in the news release. “This should offer them a dramatic new cost efficiency, for both ingested or topically applied products. We also believe that Can B Corp’s routine use of our BaroShear K45 system will allow them to increase even more the current high-quality level of their products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼